McMahon J B, Richards W L, del Campo A A, Song M K, Thorgeirsson S S
Cancer Res. 1986 Sep;46(9):4665-71.
Transforming growth factors (TGF-betas) have been shown to cause both stimulatory and inhibitory effects on cellular growth in a variety of normal and neoplastic cells. The nature of the inhibitory effects of TGF-beta on proliferation of different cell types is at present unclear. We have used freshly isolated rat hepatocytes, a normal diploid rat liver epithelial cell line (NRLM), and a subline (AFB) derived from it which was transformed in vitro by aflatoxin B1 to study the nature of TGF-beta-induced growth inhibition and its alteration following chemically induced neoplastic transformation. TGF-beta had a vastly different effect on proliferation of normal rat liver epithelial cells (both freshly isolated and NRLM cells) compared to aflatoxin B1-transformed cells. TGF-beta at 20 pg/ml caused 83% inhibition of colony formation of NRLM, whereas the growth of AFB cells was unaffected by TGF-beta at concentrations as high as 10 ng/ml. A parallel dose-dependent inhibition of DNA synthesis by TGF-beta was observed in both primary hepatocytes and NRLM cells at concentrations between 10 pg and 10 ng/ml. No inhibition of DNA synthesis was observed in AFB cells. Furthermore, TGF-beta did neither induce anchorage-independent growth of NRLM cells nor affect the growth of AFB cells in soft agar. TGF-beta-induced inhibition of the NRLM cells was irreversible in nature, since treated cells were unable to proliferate and form colonies upon removal of TGF-beta from the medium. Also, NRLM cells showed, after 4 days in the presence of 20 pg of TGF-beta per ml morphological changes characterized by cytoplasmic hypertrophy and the formation of abundant liposomal derivatives, some of which resemble lipofuscin. The finding that TGF-beta caused a high degree of irreversible inhibition of NRLM cells emphasizes the need for caution in interpreting data from inhibition studies, since most assays presently used are designed for assessing growth stimulation in vitro and do not adequately distinguish between the possible cytotoxic and/or cytostatic action of growth inhibitors.
转化生长因子(TGF-β)已被证明对多种正常细胞和肿瘤细胞的生长具有刺激和抑制作用。目前尚不清楚TGF-β对不同细胞类型增殖的抑制作用的本质。我们使用了新鲜分离的大鼠肝细胞、一种正常的二倍体大鼠肝上皮细胞系(NRLM)以及由其衍生的一个亚系(AFB),该亚系在体外被黄曲霉毒素B1转化,以研究TGF-β诱导的生长抑制的本质及其在化学诱导的肿瘤转化后的变化。与黄曲霉毒素B1转化的细胞相比,TGF-β对正常大鼠肝上皮细胞(新鲜分离的和NRLM细胞)的增殖具有截然不同的影响。20 pg/ml的TGF-β导致NRLM细胞集落形成受到83%的抑制,而AFB细胞的生长在高达10 ng/ml的TGF-β浓度下不受影响。在原代肝细胞和NRLM细胞中,在10 pg至10 ng/ml的浓度范围内观察到TGF-β对DNA合成的平行剂量依赖性抑制。在AFB细胞中未观察到DNA合成的抑制。此外,TGF-β既未诱导NRLM细胞的非锚定依赖性生长,也未影响AFB细胞在软琼脂中的生长。TGF-β对NRLM细胞的抑制本质上是不可逆的,因为当从培养基中去除TGF-β后,处理过的细胞无法增殖并形成集落。此外,在每毫升含有20 pg TGF-β的情况下培养4天后,NRLM细胞表现出形态学变化,其特征为细胞质肥大和形成大量脂质体衍生物,其中一些类似于脂褐素。TGF-β对NRLM细胞造成高度不可逆抑制这一发现强调了在解释抑制研究数据时需要谨慎,因为目前使用的大多数检测方法是为评估体外生长刺激而设计的,不能充分区分生长抑制剂可能的细胞毒性和/或细胞抑制作用。